Y-Intercept (HK)’s Connect Biopharma Holdings CNTB Stock Holding History

Y-Intercept (HK)’s Portfolio CNTB Stock Details CNTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-15,069	Closed	-$35.9K	–	1643
2026 Q2	$35.9K	Buy	+15,069	New	+$36.5K	﹤0.01%	1632

Other funds holding CNTB

Koa Wealth Management Encinitas, California $154M AUM 13.16% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Y-Intercept (HK)'s CNTB Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Connect Biopharma Holdings (CNTB) in Q3 2026, closing a stake of 15,069 shares — an estimated $35.9K sold.

Y-Intercept (HK) first reported a position in CNTB in Q2 2026 and held it in 1 quarter. The position peaked at $35.9K in Q2 2026. 6 funds tracked by Wall St. Rank hold CNTB as of Q3 2026.

Y-Intercept (HK) reported no remaining Connect Biopharma Holdings position as of Q3 2026 after selling out during the quarter.
Y-Intercept (HK) sold 15,069 Connect Biopharma Holdings shares in Q3 2026, an estimated $35.9K.
Y-Intercept (HK) first reported a position in Connect Biopharma Holdings in Q2 2026 and held it in 1 quarter.
Y-Intercept (HK)'s Connect Biopharma Holdings position peaked at $35.9K in Q2 2026.
6 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.